Information Collection

Risk Evaluation and Mitigation Strategy Programs to Promote Appropriate Medication Use and Knowledge: Physician Interviews on Experiences with REMS Programs (CDER)

IC 250770 under ICR 202205-0910-005 · OMB 0910-0847.

Documents and Forms

Documents and forms in this information collection
Document NameDocument Type
Recruitment Messages - Physician.docx Other-Recruitment Message - Physicia
Recruitment Messages - Physician.docx Other-Recruitment Message - Physicia
Recruitment Message - Professional Society.docx Other-Recruitment Message - Professi
Recruitment Message - Professional Society.docx Other-Recruitment Message - Professi
Consent Form.docx Other-Consent
Consent Form.docx Other-Consent
Interview Guide - Alemtuzumab.docx Other-Interview Guide - Alemtuzumab
Interview Guide - Alemtuzumab.docx Other-Interview Guide - Alemtuzumab
Interview Guide - Alvimopan.docx Other-Alvimopan
Interview Guide - Alvimopan.docx Other-Alvimopan
Interview Guide - Pegvaliase.docx Other-Interview Guide - Pegvaliase
Interview Guide - Pegvaliase.docx Other-Interview Guide - Pegvaliase
IRB Letter 2021P002615.pdf Other-IRB Letter
IRB Letter 2021P002615.pdf Other-IRB Letter
0847 OMB Approval Memo - REMS Physician Experience Interviews (3 Covered Drugs) 2021.docx
OMB Approval Memo
IC Document
0847 OMB Approval Memo - REMS Physician Experience Interviews (3 Covered Drugs) 2021.docx
OMB Approval Memo
IC Document

Information Collection (IC) Details

View Information Collection (IC)

layout table

Information Collection Instruments:
table that charts list of instruments
Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Recruitment Message - Physicians Recruitment Messages - Physician.docx Yes No Printable Only
Other-Recruitment Message - Professional Society Recruitment Message - Professional Society.docx Yes No Printable Only
Other-Consent Consent Form.docx Yes No Printable Only
Other-Interview Guide - Alemtuzumab Interview Guide - Alemtuzumab.docx Yes No Printable Only
Other-Alvimopan Interview Guide - Alvimopan.docx Yes No Printable Only
Other-Interview Guide - Pegvaliase Interview Guide - Pegvaliase.docx Yes No Printable Only
Other-IRB Letter IRB Letter 2021P002615.pdf Yes No Printable Only

Federal Enterprise Architecture Business Reference Module


table that charts list of burden
  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 60 0 0 0 0 60
Annual IC Time Burden (Hours) 60 0 0 0 0 60
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Documents for IC
table that charts IC Documents
Title Document Date Uploaded
OMB Approval Memo 0847 OMB Approval Memo - REMS Physician Experience Interviews (3 Covered Drugs) 2021.docx 12/15/2021
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.